Renexin CR (cilostazol/Ginkgo biloba leaf extract sustained release) / SK Bio - LARVOL DELTA

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke (clinicaltrials.gov) - P4 | N=483 | Completed | Sponsor: SK Chemicals Co., Ltd. | Recruiting ➔ Completed

Trial completion • Cardiovascular • Ischemic stroke

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke (clinicaltrials.gov) - P4 | N=500 | Recruiting | Sponsor: SK Chemicals Co., Ltd. | Trial completion date: Jan 2025 ➔ Oct 2025 | Trial primary completion date: Oct 2024 ➔ Sep 2025

Trial completion date • Trial primary completion date • Cardiovascular • Ischemic stroke

A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy. (clinicaltrials.gov) - P4 | N=105 | Completed | Sponsor: SK Chemicals Co., Ltd. | Recruiting ➔ Completed

Trial completion

A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy. (clinicaltrials.gov) - P4 | N=100 | Recruiting | Sponsor: SK Chemicals Co., Ltd.

New P4 trial

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke (clinicaltrials.gov) - P4 | N=500 | Recruiting | Sponsor: SK Chemicals Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Ischemic stroke

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke (clinicaltrials.gov) - P4 | N=500 | Not yet recruiting | Sponsor: SK Chemicals Co., Ltd.

New P4 trial • Cardiovascular • Ischemic stroke